Skip Header

Contribute Send feedback
Read comments (?) or add your own

P20263 (PO5F1_MOUSE) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 122. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (3) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
POU domain, class 5, transcription factor 1
Alternative name(s):
NF-A3
Octamer-binding protein 3
Short name=Oct-3
Octamer-binding protein 4
Short name=Oct-4
Octamer-binding transcription factor 3
Short name=OTF-3
Gene names
Name:Pou5f1
Synonyms:Oct-3, Oct-4, Otf-3, Otf3
OrganismMus musculus (Mouse)
Taxonomic identifier10090 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeMusMus

Protein attributes

Sequence length352 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3'). Forms a trimeric complex with SOX2 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206. Critical for early embryogenesis and for embryonic stem cell pluripotency. Ref.8 Ref.9

Subunit structure

Interacts with PKM2. Interacts with WWP2 By similarity. Interacts with UBE2I and ZSCAN10. Ref.8 Ref.10

Subcellular location

Nucleus. Note: Expressed in a diffuse and slightly punctuate pattern. Ref.8 Ref.9

Tissue specificity

Expressed the totipotent and pluripotent stem cells of the pregastrulation embryo. Also expressed in primordial germ cells and in the female germ line. Absent from adult tissues. Ref.1 Ref.2

Developmental stage

Down-regulated during differentiation to endoderm and mesoderm. Ref.1

Induction

Repressed by retinoic acid (RA). Ref.2 Ref.4

Domain

The POU-specific domain mediates interaction with PKM2 By similarity. Ref.12

Post-translational modification

Sumoylation enhances the protein stability, DNA binding and transactivation activity. Sumoylation is required for enhanced YES1 expression.

Ubiquitinated; undergoes 'Lys-63'-linked polyubiquitination by WWP2 leading to proteasomal degradation. Ref.11

Biotechnological use

POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4 are the four Yamanaka factors. When combined, these factors are sufficient to reprogram differentiated cells to an embryonic-like state designated iPS (induced pluripotent stem) cells. iPS cells exhibit the morphology and growth properties of ES cells and express ES cell marker genes. Ref.7

Sequence similarities

Belongs to the POU transcription factor family. Class-5 subfamily.

Contains 1 homeobox DNA-binding domain.

Contains 1 POU-specific domain.

Ontologies

Keywords
   Biological processTranscription
Transcription regulation
   Cellular componentNucleus
   DomainHomeobox
   LigandDNA-binding
   Molecular functionDevelopmental protein
   PTMIsopeptide bond
Ubl conjugation
   Technical term3D-structure
Complete proteome
Reference proteome
Gene Ontology (GO)
   Biological processectodermal cell fate commitment

Inferred from direct assay. Source: MGI

endodermal cell fate commitment

Inferred from direct assay. Source: MGI

germ-line stem cell maintenance

Inferred from mutant phenotype. Source: MGI

mRNA transcription from RNA polymerase II promoter

Inferred from direct assay. Source: BHF-UCL

mesodermal cell fate commitment

Inferred from direct assay. Source: MGI

negative regulation of calcium ion-dependent exocytosis

Inferred from direct assay. Source: MGI

negative regulation of transcription, DNA-dependent

Inferred from direct assay Ref.3. Source: MGI

positive regulation of transcription from RNA polymerase II promoter

Inferred from direct assay Ref.1. Source: MGI

regulation of asymmetric cell division

Inferred from expression pattern. Source: BHF-UCL

response to retinoic acid

Inferred from direct assay. Source: MGI

trophectodermal cell differentiation

Inferred from genetic interaction. Source: MGI

   Cellular componentcytoplasm

Inferred from direct assay. Source: MGI

soluble fraction

Inferred from direct assay. Source: MGI

transcription factor complex

Inferred from direct assay. Source: MGI

transcriptional repressor complex

Inferred from direct assay. Source: MGI

   Molecular functionchromatin binding

Inferred from direct assay. Source: MGI

sequence-specific DNA binding

Inferred from direct assay Ref.2. Source: MGI

sequence-specific DNA binding RNA polymerase II transcription factor activity

Inferred from direct assay. Source: BHF-UCL

transcription corepressor activity

Inferred from direct assay. Source: MGI

transcription factor binding

Inferred from physical interaction. Source: UniProtKB

transcription regulatory region DNA binding

Inferred from direct assay. Source: UniProtKB

ubiquitin protein ligase binding

Inferred from physical interaction. Source: BHF-UCL

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 352352POU domain, class 5, transcription factor 1
PRO_0000100749

Regions

Domain131 – 20575POU-specific
DNA binding223 – 28260Homeobox

Amino acid modifications

Cross-link118Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.6 Ref.8 Ref.9

Experimental info

Mutagenesis1181K → R: Absence of sumoylation. Enhanced protein degradation. Reduced self-renewal ability in ES cells. 70% lower expression of YES1. Reduced DNA binding. No change in nuclear location. No change in nuclear localization. Absence of sumoylation; when associated with R-215 and R-244. Ref.6 Ref.8 Ref.9
Mutagenesis1201E → A: Absence of sumoylation. Enhanced protein degradation. Reduced self-renewal ability in ES cells. 55% lower expression of YES1. Ref.8
Mutagenesis2151K → R: No change in sumoylation; when associated with R-244. Loss of sumoylation. No change in nuclear localization; when associated with R-118 and R-244. Ref.8
Mutagenesis2441K → R: No change in sumoylation. No change in sumoylation; when associated with R-215. Loss of sumoylation; when associated with R-118 and R-215. No change in nuclear localization; when associated with R-118 and R-215. Ref.8
Sequence conflict1 – 2828Missing in CAA36682. Ref.2
Sequence conflict291V → M in CAA36682. Ref.2
Sequence conflict311P → S in AAA39844. Ref.4
Sequence conflict311P → S in AAB19896. Ref.4

Secondary structure

.......... 352
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
P20263 [UniParc].

Last modified February 1, 1991. Version 1.
Checksum: 757E41DF52286714

FASTA35238,216
        10         20         30         40         50         60 
MAGHLASDFA FSPPPGGGDG SAGLEPGWVD PRTWLSFQGP PGGPGIGPGS EVLGISPCPP 

        70         80         90        100        110        120 
AYEFCGGMAY CGPQVGLGLV PQVGVETLQP EGQAGARVES NSEGTSSEPC ADRPNAVKLE 

       130        140        150        160        170        180 
KVEPTPEESQ DMKALQKELE QFAKLLKQKR ITLGYTQADV GLTLGVLFGK VFSQTTICRF 

       190        200        210        220        230        240 
EALQLSLKNM CKLRPLLEKW VEEADNNENL QEICKSETLV QARKRKRTSI ENRVRWSLET 

       250        260        270        280        290        300 
MFLKCPKPSL QQITHIANQL GLEKDVVRVW FCNRRQKGKR SSIEYSQREE YEATGTPFPG 

       310        320        330        340        350 
GAVSFPLPPG PHFGTPGYGS PHFTTLYSVP FPEGEAFPSV PVTALGSPMH SN 

« Hide

References

« Hide 'large scale' references
[1]"A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo."
Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W.J., Staudt L.
Nature 345:686-692(1990) [PubMed: 1972777] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, DEVELOPMENTAL STAGE.
Tissue: Embryonic carcinoma.
[2]"New type of POU domain in germ line-specific protein Oct-4."
Schoeler H.R., Ruppert S., Suzuki N., Chowdhury K., Gruss P.
Nature 344:435-439(1990) [PubMed: 1690859] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, INDUCTION.
Tissue: Embryonic carcinoma.
[3]"A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells."
Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M., Hamada H.
Cell 60:461-472(1990) [PubMed: 1967980] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[4]"The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer."
Okazawa H., Okamoto K., Ishino F., Ishino-Kaneko T., Takeda S., Toyoda Y., Muramatsu M., Hamada H.
EMBO J. 10:2997-3005(1991) [PubMed: 1915274] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], SEQUENCE REVISION, INDUCTION.
[5]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Strain: C57BL/6J.
Tissue: Embryo.
[6]"Inhibition of DNA binding of Sox2 by the SUMO conjugation."
Tsuruzoe S., Ishihara K., Uchimura Y., Watanabe S., Sekita Y., Aoto T., Saitoh H., Yuasa Y., Niwa H., Kawasuji M., Baba H., Nakao M.
Biochem. Biophys. Res. Commun. 351:920-926(2006) [PubMed: 17097055] [Abstract]
Cited for: SUMOYLATION AT LYS-118, MUTAGENESIS OF LYS-118.
[7]"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors."
Takahashi K., Yamanaka S.
Cell 126:663-676(2006) [PubMed: 16904174] [Abstract]
Cited for: BIOTECHNOLOGY.
[8]"Post-translational modification of POU domain transcription factor Oct-4 by SUMO-1."
Zhang Z., Liao B., Xu M., Jin Y.
FASEB J. 21:3042-3051(2007) [PubMed: 17496161] [Abstract]
Cited for: SUMOYLATION AT LYS-118, MUTAGENESIS OF LYS-118; GLU-120; LYS-215 AND LYS-244, FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH UBE2I.
[9]"Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation."
Wei F., Schoeler H.R., Atchison M.L.
J. Biol. Chem. 282:21551-21560(2007) [PubMed: 17525163] [Abstract]
Cited for: SUMOYLATION AT LYS-118, MUTAGENESIS OF LYS-118, FUNCTION, SUBCELLULAR LOCATION.
[10]"Zfp206, Oct4, and Sox2 are integrated components of a transcriptional regulatory network in embryonic stem cells."
Yu H.B., Kunarso G., Hong F.H., Stanton L.W.
J. Biol. Chem. 284:31327-31335(2009) [PubMed: 19740739] [Abstract]
Cited for: INTERACTION WITH ZSCAN10.
[11]"Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner."
Liao B., Jin Y.
Cell Res. 20:332-344(2010) [PubMed: 19997087] [Abstract]
Cited for: UBIQUITINATION.
[12]"Secondary structure of the oct-3 POU homeodomain as determined by 1H-15N NMR spectroscopy."
Morita E.H., Shirakawa M., Hayashi F., Imagawa M., Kyogoku Y.
FEBS Lett. 321:107-110(1993) [PubMed: 8097478] [Abstract]
Cited for: STRUCTURE BY NMR OF POU DOMAIN.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
M34381 mRNA. Translation: AAA39844.1. Sequence problems.
X52437 mRNA. Translation: CAA36682.1.
S58426 expand/collapse EMBL AC list , S58422, S58423, S58424, S58425 Genomic DNA. Translation: AAB19896.1.
BC068268 mRNA. Translation: AAH68268.1.
IPIIPI00117218.
PIRA34672.
S17313.
RefSeqNP_038661.2. NM_013633.3.
UniGeneMm.17031.

3D structure databases

PDBe
RCSB PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
1OCPNMR-A217-282[»]
3L1PX-ray2.80A/B131-282[»]
ProteinModelPortalP20263.
SMRP20263. Positions 131-282.
ModBaseSearch...

Protein-protein interaction databases

DIPDIP-29931N.
IntActP20263. 104 interactions.
STRINGP20263.

PTM databases

PhosphoSiteP20263.

Proteomic databases

PRIDEP20263.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENSMUST00000025271; ENSMUSP00000025271; ENSMUSG00000024406.
GeneID18999.
KEGGmmu:18999.
UCSCuc008chu.1. mouse.

Organism-specific databases

CTD5460.
MGIMGI:101893. Pou5f1.

Phylogenomic databases

eggNOGmaNOG13238.
GeneTreeENSGT00580000081294.
HOGENOMHBG282577.
HOVERGENHBG057998.
InParanoidP20263.
OMALENMFLQ.
OrthoDBEOG46MBK1.

Gene expression databases

ArrayExpressP20263.
BgeeP20263.
CleanExMM_POU5F1.
GenevestigatorP20263.

Family and domain databases

InterProIPR001356. Homeobox.
IPR017970. Homeobox_CS.
IPR009057. Homeodomain-like.
IPR012287. Homeodomain-rel.
IPR010982. Lambda_DNA-bd.
IPR013847. POU.
IPR015585. POU_dom_5.
IPR000327. POU_specific.
[Graphical view]
Gene3DG3DSA:1.10.260.40. G3DSA:1.10.260.40. 1 hit.
G3DSA:1.10.10.60. Homeodomain-rel. 1 hit.
KOK09367.
PANTHERPTHR11636:SF15. POU_5. 1 hit.
PfamPF00046. Homeobox. 1 hit.
PF00157. Pou. 1 hit.
[Graphical view]
PRINTSPR00028. POUDOMAIN.
SMARTSM00389. HOX. 1 hit.
SM00352. POU. 1 hit.
[Graphical view]
SUPFAMSSF46689. Homeodomain_like. 1 hit.
SSF47413. Lambda_like_DNA. 1 hit.
PROSITEPS00027. HOMEOBOX_1. 1 hit.
PS50071. HOMEOBOX_2. 1 hit.
PS00035. POU_1. 1 hit.
PS00465. POU_2. 1 hit.
PS51179. POU_3. 1 hit.
[Graphical view]
ProtoNetSearch...

Other

NextBio295410.
SOURCESearch...

Entry information

Entry namePO5F1_MOUSE
AccessionPrimary (citable) accession number: P20263
Secondary accession number(s): Q63843
Entry history
Integrated into UniProtKB/Swiss-Prot: February 1, 1991
Last sequence update: February 1, 1991
Last modified: January 25, 2012
This is version 122 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program

Relevant documents

MGD cross-references

Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families